Managing the problem of depression in pregnancy
A discussion of the tricky problem of depression in women during pregnancy, from the Institute of Psychiatry at King’s College, London, appears in the 12 May issue of the BMJ. It points out that rates of depression are higher during the childbearing years than at any other time and vary from 7 to 15 per cent in economically developed countries to 19 to 25 per cent in less developed ones. The relapse rate in pregnant women with a history of recurrent mood disorder may be as high as 50 per cent.
Predisposition to such an effect is influenced by poverty, lack of education
and sex inequality. Exposure to domestic violence adds to the risk, as
do poor social support, adolescence and single status.
Most women welcome pregnancy, but it is a major physiological and psychological
event and, added to other chronic stressors, may present an unmanageable
situation. The biological changes during pregnancy directly affect mood,
since sex steroids are increased and affect parts of the brain regulating
it, while overactivity of the hypothalamic-pituitary-adrenal system increases.
Stopping maintenance medication may be an important contributory factor.
The discontinuation of antidepressants after conception has been associated
with relapse in some two thirds of women. The risk of suicide is low,
but it may be a common cause of maternal deaths in the year after birth.
Antenatal depression may have a harmful influence upon the development
of a child’s central nervous system. Moreover, unhealthy behaviours
associated with depression, such as smoking, alcohol and other substance
abuse, associated with poor attendance for obstetric care, add to the
hazards. Behaviour that presents a health risk apparently has a strong
effect on intrauterine growth, while psychological stress has more effect
on preterm delivery.
Treating depression in pregnancy may involve psychotherapy for mild problems
but, if the patients has a history of severe or recurrent depression,
then treatment with antidepressants may be called for.
Paroxetine is suspected of being more liable to cause cardiac abnormalities
than are other antidepressants. A serotonin withdrawal syndrome with
hypotonia, irritability, excessive crying, sleeping difficulties and
mild respiratory distress is more likely to occur with paroxetine than
with other drugs of the same class.
Back to Top
|